HSBC Mutual Fund crosses 5% in Thyrocare, holds 6.63%

Creeping Acquisition Near ThresholdOwnership Changes View source PDF Explain this filing

THYROCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.6%Reaction day

₹620.00

prior close

₹609.10

announcement price

In-mkt

timing

Nifty Microcap 250market+0.4%-2.0% vs market

Healthcare Service Provider peers, median of 28sector+0.1%-1.7% vs sector

On the reaction day the stock moved 2.0 pts less than Nifty Microcap 250 and 1.7 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.6+0.4-2.0+0.1-1.7

Next day

-6.5-0.2-6.2-0.2-6.2

-8.5+0.3-8.9-0.1-8.5

-8.7+0.6-9.3+0.5-9.2

-5.5+0.8-6.3+0.0-5.5

-3.9+0.4-4.3+0.6-4.5

-6.0+0.7-6.7+0.1-6.1

15d

-8.0+2.0-10.0+1.4-9.4

-10.5+0.7-11.2+1.1-11.6

-24.2-3.4-20.8-3.0-21.2

—————

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 28Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

HSBC Mutual Fund bought 29,99,731 shares (1.88%) of Thyrocare Technologies via open market on Aug 13, 2026. This lifted its stake from 4.75% (75,57,935 shares) to 6.63% (1,05,57,666 shares), triggering the 5% SEBI SAST disclosure threshold. The fund is classified as a non-promoter acquirer.

Likely market impact

FPI buying signals institutional confidence in Thyrocare; HSBC is now a significant non-promoter shareholder above 6.5%.